DOCSLIB.ORG

Polar Body Biopsy – Advantages of the Eppendorf Micromanipulation System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Polar Body Biopsy – Advantages of the Eppendorf Micromanipulation System APPLICATION NOTE No. 140 Polar body biopsy – Advantages of the Eppendorf micromanipulation system Markus Montag University Gynecological Hospital Heidelberg, Department of Gynecological Endocrinology and Fertility Disorders, Heidelberg, Germany Abstract A well-established technique which is used in preim- is followed by detection of certain chromosomes using plantation genetic diagnostics (PGD) is polar body (PB) fluorescencein-situ hybridization (FISH) or detection of biopsy. The polar bodies of the oocyte are extruded at all chromosomes by comparative genomic hybridization. the conclusion of the meiotic division; normally the first Using the Eppendorf micromanipulation system with polar body is noted after ovulation; the second polar body manual injectors and the electronic TransferMan® 4m is observed 2–3 h following entry of the sperm into the micromanipulators in combination with the OCTAX Laser oocyte. Removal of the first and second polar bodies takes Shot™ System, fast and sensitive handling of the oocyte place 6–12 hours after the performance of intracytoplasmic and polar bodies can be guaranteed. sperm injection (ICSI). The biopsy of the polar bodies Introduction Over the past few decades the mean age of women conceiving their first child has steadily increased. However, advanced maternal age lowers the chance for pregnancy and increases the risk of miscarriage once a woman is pregnant. One major problem strongly correlated to maternal age is the occurrence of numerical chromosomal abnormalities in human oocytes. In women who are 40 years old and older, up to 70 % of their oocytes can be chromosomally abnormal [1, 2]. In the context of assisted reproduction treatment, it is possible to identify and exclude such oocytes, thereby increasing the success rate. The underlying technique is the biopsy of the first and second polar bodies (Figure 1), followed by detection of certain chromosomes using fluorescence in-situ hybrid- ization (FISH) or detection of all chromosomes by compara- tive genomic hybridization (CGH). To understand these techniques it is important to be familiar with certain aspects of fertilization and subsequent early embryo development. The cell division that results in sperm and oocytes contain- Fig. 1: Biopsy of 1st and 2nd polar bodies ing 23 chromosomes each is called meiosis. APPLICATION NOTE I No. 140 I Page 2 In their resting state, eggs exist in a state of arrested meiosis Materials and Methods and still contain all 23 paired chromosomes. During ovula- tion, meiosis resumes, and the egg extrudes one set of its Compared to ICSI, polar body biopsy requires additional 23 chromosomes in a small structure called the first polar micromanipulation steps; thus it greatly benefits from the body. Soon after fertilization occurs, a second polar body, proper instrumentation, especially the Eppendorf Transfer- containing 23 maternal chromatids, is expelled. On the day Man 4m (Figure 2) with its special features which render after oocyte retrieval, both polar bodies are visible by light the procedure as economic as possible. The use of applica- microscopy in the normally fertilized oocyte. tion specific masks of the TransferMan 4m micromanipu- Polar bodies with missing or excess chromosomal material lator with predefined as well as freely definable softkey are indicative of an oocyte that contains either an excess functions eases the individual workflow process. The unique of chromosomes, which, after fertilization, results in an DualSpeed joystick enables precise and intuitive movement embryo with a trisomy, or of an oocyte which is missing along all three axes when handling the oocyte as well as chromosomes, which, again after fertilization, results in an dynamic movements while covering greater distances (see embryo with a monosomy. Thus, polar body biopsy provides Figure 3). This helps reducing exposure time of the oocytes an indirect diagnosis of the oocyte for aneuploidy testing. to stressful conditions outside the incubator, and it mini- This method can also be applied to couples with a balanced mizes the risk of losing the material of interest. translocation of the mother and to couples who are aware of maternal predisposition for a genetic disease that may manifest itself in the child. Polar body biopsy was first presented in 1990 [3], and sev- eral aspects of this technique have been technically refined including the use of lasers and electronic micromanipulators to facilitate the biopsy procedure [4]. speed 1 2 [µm/s] 0 Fig. 3: Movement in direct correlation with the deflection of the joystick. 1: proportional kinetics, 2: area of dynamic movement. The ratio of the dynamic movement may be adjusted according to the proportional range. Fig. 2: Eppendorf Workstation for IVF APPLICATION NOTE I No. 140 I Page 3 Devices for polar body biopsy the culture dish with a glass slide, and position 3B for releas- > Inverted microscope with a heated plate and modulation ing the polar bodies into the water droplets on the slide for contrast objectives later FISH. > OCTAX Laser Shot™ System (OCTAX, MTG) Additionally, two positions are reserved for the manipulator > 2 TransferMan 4m micromanipulators (Eppendorf) used for holding the oocyte: position 1H for holding the > CellTram ® Air microinjector for holding the embryo oocyte during biopsy and position 2H for the changing of (Eppendorf) droplets in the dish. Once stored, these positions can be > CellTram ® vario microinjector for removal and transfer of automatically activated by pressing the relevant position the polar body (Eppendorf) button on the device. Alternatively, the positions can be > Biopsy capillary, for laser-assisted biopsy of polar bodies relocated in succession by clicking the joystick key twice (recommended: 19 µm inner diameter, 35° tip angle) (double-click). This set-up enables a fast and economic > Holding capillary, for holding of oocytes (recommended: change from one capillary working position to another, 15 µm inner diameter, 100 µm outer diameter, 35° tip but most importantly it controls the capillary that holds angle) the aspirated polar bodies, thus helping to reduce the rate of lost polar bodies to less than 0.5 %. An overview of the Polar body biopsy different positions required during the biopsy procedure is The most important feature of the TransferMan 4m for polar shown in Figure 5a–b. body biopsy is its ability to store several freely definable capillary positions. Up to five positions can be stored. For the polar body biopsy procedure, as it is performed in our laboratory, one needs to store three user-defined posi- tions; hence the use of the application mask »Cell Transfer« with three softkeys dedicated to position storage is recom- mended. In addition, using this mask, a vertical limit can be defined to avoid capillary breakage (see Figure 4). One softkey is free for individual settings. Fig. 5a: Stored positions for polar body biopsy. Fig. 4: Application mask »Cell transfer« with three softkeys: for position storage and one for definition of a vertical limit (Z-axis limit) to avoid capillary breakage. One softkey is free for individual programming. The polar body biopsy is performed in a culture dish. A biopsy capillary is used to transfer the polar bodies directly into a drop of water on a glass slide for the purpose of FISH analysis or into another droplet in the dish for later transfer to PCR Fig. 5b: Stored positions for polar body biopsy. tubes if array-CGH is to be performed. The three user-defined capillary positions are used as fol- lows: position 1B for biopsy/release into adjacent droplets in the case of array-CGH, position 2B for easily replacing APPLICATION NOTE I No. 140 I Page 4 For polar body biopsy we recommend setting up a dish with position outside and far above the culture dish by activating a single droplet that contains PVP and two/three rows of the »home« key, and if required, the motors are swiveled out droplets for FISH/array-CGH, 3–5 µL each, which contain to the side of the microscope. Now the dish can be removed buffered culture medium. The buffered culture medium is safely so that the oocytes may be transferred to another required for maintenance of the proper pH during manipula- culture dish. tion outside the incubator. PVP is used for rinsing the biopsy capillary, which helps to avoid polar bodies sticking to the Transfer of polar bodies to a slide for later FISH analysis inner glass wall. The left row of droplets is used for the oo- The dish still holding the polar bodies is placed back on the cytes (one per droplet) and the right row for sampling of the microscope stage, the motors are swiveled back in and the polar bodies after biopsy. In the case of array-CGH two rows biopsy capillary is lowered automatically by pressing the for polar body sampling are required as polar bodies 1 and 2 »home« key again. Next the capillary can be moved directly need to be processed separately. In preparation for biopsy, into position 1B by pressing »Pos 1«. The polar bodies cor- an oocyte is gently aspirated by the holding capillary and responding to oocyte 1 are then aspirated into the biopsy affixed as closely as possible to the bottom of the dish. This capillary. Next, the capillary is moved to position 2B (by position is stored as position 1H. Rotation of the oocyte may pressing »Pos 2«), the culture dish is removed, and a glass be necessary in order to obtain proper alignment of the first slide holding a 0.2 µL droplet of pure water is placed under and second polar bodies in one focal plane (Figure 6a). This the capillary. The biopsy capillary still holding the polar focal plane defines position 1B for the biopsy capillary, and, bodies is lowered into the water droplet so that it just touch- once adjusted, this position should also be stored. Follow- es the glass surface.
Load more

Recommended publications
  • Background Document on Preimplantation and Prenatal Genetic Testing
    DH-BIO/INF (2015) 6 Background document on preimplantation and prenatal genetic testing Clinical Situation Legal situation1 1 Part II of this document presents the legal situation in Council of Europe member states and will be regularly updated (last update 7 May 2015). The updated text is highlighted in green. TABLE OF CONTENTS Introduction ............................................................................................................... 3 Part I. Preimplantation (PGD) and Prenatal (PND) Genetic Diagnosis. Clinical practice, Trends and Technological Developments ................................................... 4 1. Genetic diseases .............................................................................................. 4 1.1 Monogenic diseases ......................................................................................... 4 1.2 Polygenic diseases or multifactorial diseases ................................................... 5 1.3 Chromosomal diseases .................................................................................... 5 2. Preimplantation genetic diagnosis on embryonic cells ...................................... 5 2.1 General description of the procedure ................................................................ 5 2.2 PGD uses ......................................................................................................... 6 2.2.1 Main uses of PGD for medical indications ......................................................... 6 2.2.2 Use of PGD for the benefit of the health
    [Show full text]
  • Oocyte Polarity: a Sign of Oocyte Quality?
    Biology of Reproduction Unit Oocyte polarity: a sign of oocyte quality? Carlos E. Plancha1,2 1 Unidade de Biologia da Reprodução, Inst. Histologia e Biologia do Desenvolvimento, . Faculdade de Medicina de Lisboa, Portugal 2 CEMEARE – Centro Médico de Assistência à Reprodução, Lisboa, Portugal 7th ESHRE Campus on Mammalian Folliculogenesis and Oogenesis Stresa, Italy 19-21 April, 2012 DISCLOSURE CE Plancha does not have any commercial and/or financial relationship with manufacturers of pharmaceuticals, laboratory supplies and/or medical devices. 7th ESHRE Campus on Mammalian Folliculogenesis and Oogenesis Stresa, Italy 19-21 April, 2012 Presentation outline 1. Oocyte quality: impact, acquisition and approaches 2. Oocyte polarity: a feature of oocyte maturation 3. Oocyte polarity: a reflection of oocyte quality? 4. Future challenges 7th ESHRE Campus on Mammalian Folliculogenesis and Oogenesis Stresa, Italy 19-21 April, 2012 Presentation outline 1. Oocyte quality: impact, acquisition and approaches 2. Oocyte polarity: a feature of oocyte maturation 3. Oocyte polarity: a reflection of oocyte quality? 4. Future challenges 7th ESHRE Campus on Mammalian Folliculogenesis and Oogenesis Stresa, Italy 19-21 April, 2012 Oocyte Quality: a major determinant of Embryo Quality and Reproductive Success % Transfers that resulted in Live Births for ART Cycles using Fresh Embryos, from Own and Donor Eggs, by Woman’s Age Oocyte Quality is an oocyte 2008 Assisted Reproductive Technology Report attribute of major relevance in the Centers for Disease Control
    [Show full text]
  • Preimplantation Genetic Testing for Aneuploidy (PGT-­A): the Biology, the Technology and the Clinical Outcomes
    Aust N Z J Obstet Gynaecol 2019; 1–8 DOI: 10.1111/ajo.12960 OPINION Preimplantation genetic testing for aneuploidy (PGT-­A): The biology, the technology and the clinical outcomes Hayden Anthony Homer1,2,3 1Christopher Chen Oocyte Biology Research Laboratory, UQ Centre Preimplantation genetic testing for aneuploidy (PGT-­A) seeks to identify preim- for Clinical Research, The University plantation embryos with a normal chromosome complement (euploid) during in of Queensland, Brisbane, Queensland, Australia vitro fertilisation (IVF). By sifting out embryos with abnormal chromosome num- 2Reproductive Endocrinology and bers (aneuploid), PGT-­A should theoretically improve pregnancy success. Infertility Clinic, Royal Brisbane However, earlier versions of PGT-­A were ineffective, and in some cases, detri- & Women's Hospital, Brisbane, Queensland, Australia mental, due to biopsy-­induced trauma and because the technology at the time 3Queensland Fertility Group, Brisbane, could analyse only a fraction of all chromosomes. More recently, the emergence Queensland, Australia of technologies enabling all chromosomes to be analysed and a switch to less Correspondence: Professor Hayden traumatic blastocyst-­stage biopsy have seen widespread uptake of PGT-­A. Anthony Homer, Christopher Chen Assessing the full impact of blastocyst biopsy PGT-­A requires consideration of Oocyte Biology Research Laboratory, UQ Centre for Clinical Research, The multiple factors, including embryonic mosaicism, sensitivity of the technological University of Queensland, Building platform used, embryo loss during long-term­ in vitro culture, embryo cryo- 71/918, Royal Brisbane & Women's Hospital Campus, Herston, QLD 4029, preservation and inter-­clinic variability in expertise. Significantly, there hasn‘t Australia. yet been an appropriately designed randomised controlled trial (RCT) of blasto- Email: [email protected] cyst biopsy PGT-­A analysed by intention-to-­ ­treat that accounts for all these pa- Conflicts of Interest: The author report no conflicts of interest.
    [Show full text]
  • New Advances of Preimplantation and Prenatal Genetic Screening and Noninvasive Testing As a Potential Predictor of Health Status of Babies
    Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 306505, 8 pages http://dx.doi.org/10.1155/2014/306505 Review Article New Advances of Preimplantation and Prenatal Genetic Screening and Noninvasive Testing as a Potential Predictor of Health Status of Babies Tanya Milachich SAGBAL Dr. Shterev, IVF Unit, Hristo Blagoev 25-31, 1330 Sofia, Bulgaria Correspondence should be addressed to Tanya Milachich; tanya [email protected] Received 24 December 2013; Revised 13 February 2014; Accepted 15 February 2014; Published 24 March 2014 Academic Editor: Irma Virant-Klun Copyright © 2014 Tanya Milachich. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The current morphologically based selection of human embryos for transfer cannot detect chromosome aneuploidies. So far, only biopsy techniques have been able to screen for chromosomal aneuploidies in the in vitro fertilization (IVF) embryos. Preimplantation genetic diagnosis (PGD) or screening (PGS) involves the biopsy of oocyte polar bodies or embryonic cells and has become a routine clinical procedure in many IVF clinics worldwide, including recent development of comprehensive chromosome screening of all 23 pairs of chromosomes by microarrays for aneuploidy screening. The routine preimplantation and prenatal genetic diagnosis (PND) require testing in an aggressive manner. These procedures may be invasive to the growing embryo and fetus and potentially could compromise the clinical outcome. Therefore the aim of this review is to summarize not only the new knowledge on preimplantation and prenatal genetic diagnosis in humans, but also on the development of potential noninvasive embryo and fetal testing that might play an important role in the future.
    [Show full text]
  • Live Births After Polar Body Biopsy and Frozen-Thawed Cleavage Stage Embryo Transfer: Case Report
    JBRA Assisted Reproduction 2016;20(4):253-256 doi: 10.5935/1518-0557.20160049 Case Report Live births after polar body biopsy and frozen-thawed cleavage stage embryo transfer: case report Fernando Guimarães1, Matheus Roque1,2, Marcello Valle1, Alessandra Kostolias1, Rodrigo A de Azevedo1, Ciro D Martinhago3, Marcos Sampaio4, Selmo Geber2,4 1ORIGEN – Center for Reproductive Medicine, Rio de Janeiro/RJ - Brazil 2UFMG – Universidade Federal de Minas Gerais, Belo Horizonte/MG - Brazil 3Chromosome Genomic Medicine, São Paulo/SP - Brazil 4ORIGEN – Center for Reproductive Medicine, Belo Horizonte/MG - Brazil ABSTRACT 2002). To perform the biopsy, it is important to cause a Pre-implantation genetic diagnosis (PGD) or screening disruption of the zona pellucida of the oocyte or embryo (PGS) technology, has emerged and developed in the past occurs, which can be performed mechanically, chemically few years, benefiting couples as it allows the selection and or using laser (Brezina et al., 2012). The key point of PGD/ transfer of healthy embryos during IVF treatments. These PGS is to have access to the genetic material to be evalu- techniques can be performed in oocytes (polar-body biop- ated, without compromising the material analyzed and the sy) or embryos (blastomere or trophectoderm biopsy). In quality of the oocyte/embryo (Xu & Montag, 2012). this case report, we describe the first two live births to be Polar body (PB) biopsy was introduced in 1990 (Ver- published in Brazil after a polar-body (PB) biopsy. In case linsky et al., 1990), and it is associated with a less inva- 1, a 42-year-old was submitted to PB biopsy with PGS due sive technique, presenting advantages, because it main- to advanced maternal age and poor ovarian reserve.
    [Show full text]
  • Preimplantation Genetic Diagnosis
    REVIEW Review Preimplantation genetic diagnosis Karen Sermon, André Van Steirteghem, Inge Liebaers Preimplantation genetic diagnosis (PGD) was introduced at the beginning of the 1990s as an alternative to prenatal diagnosis, to prevent termination of pregnancy in couples with a high risk for offspring affected by a sex-linked genetic disease. At that time, embryos obtained in vitro were tested to ascertain their sex, and only female embryos were transferred. Since then, techniques for genetic analysis at the single-cell level, involving assessment of first and second polar bodies from oocytes or blastomeres from cleavage-stage embryos, have evolved. Fluorescence in-situ hybridisation (FISH) has been introduced for the analysis of chromosomes and PCR for the analysis of genes in cases of monogenic diseases. In-vitro culture of embryos has also improved through the use of sequential media. Here, we provide an overview of indications for, and techniques used in, PGD, and discuss results obtained with the technique and outcomes of pregnancies. A brief review of new technologies is also included. Preimplantation genetic diagnosis (PGD) is an early form of described; fluorescence in-situ hybridisation (FISH) has prenatal diagnosis, in which embryos created in vitro are since replaced PCR as a reliable method for the sexing of analysed for well-defined genetic defects; only those free of embryos,7,8 and has been widely used for PGD-AS and for the defects are replaced into the womb.1 The technique is detection of imbalanced forms of chromosomal used mainly in two broad indication groups. The first group aberrations.2,9,10 are individuals at high risk of having a child with a genetic Here, we discuss methods used for diagnosis of genetic disease—eg, carriers of a monogenic disease or of diseases, indications for PGD and PGD-AS, results chromosomal structural aberrations, such as transloca- obtained with the techniques, and subsequent outcomes tions—who have repeatedly opted to terminate their of pregnancies.
    [Show full text]
  • Proctor Booklet
    3.11 C: Meiosis Quiz PROCTOR VERSION 1. Which diagram best illustrates the processes of DNA replication, meiosis, and separation of sister chromatids? (A) Distractor Rationale: This answer suggests the student may understand that meiosis involves the splitting of homologous chromosomes, but does not understand that the first step in this process is the replication of all chromosomes to create a pair of two chromatids attached by a centromere (the X-shaped structures), and that the last step is the separation of sister chromatids in meiosis II to create four daughter cells, each containing a long chromosome and a short chromosome. (B) Distractor Rationale: This answer suggests the student may understand that meiosis involves the replication of all chromosomes and the pairing up and separation of homologous chromosomes, but does not understand that the final step in this process is the separation of sister chromatids in meiosis II to produce four haploid daughter cells, each with the haploid number of chromosomes. (C) Page 1 of 8 3.11 C: Meiosis Quiz PROCTOR VERSION Distractor Rationale: This answer suggests the student may understand that meiosis involves the replication of all chromosomes and the separation of sister chromatids, but does not realize that the first division involves the pairing up and separation of homologous chromosomes, and that this is then followed by a second division that produces four daughter cells, each with the haploid number of chromosomes. (D) Rationale: This answer suggests the student understands that the representation accurately depicts how the process of meiosis produces four haploid cells from one diploid parent cell: the formation of chromosomes, formation of the spindle complex, pairing of homologs, lining up of homologs on the equator, migration of chromosomes, and two divisions.
    [Show full text]
  • A Review of the Human Oocyte and ICSI Practice
    in vivo 30 : 387-400 (2016) Review Making ICSI Safer and More Effective: A Review of the Human Oocyte and ICSI Practice MARA SIMOPOULOU 1,2 , POLINA GIANNELOU 2, PANAGIOTIS BAKAS 2, LAERTIS GKOLES 2, THEODOROS KALAMPOKAS 2, KONSTANTINOS PANTOS 3 and MICHAEL KOUTSILIERIS 1 1Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 2Assisted Conception Unit, Second Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 3Centre for Human Reproduction, Genesis Hospital, Athens, Greece Abstract. Intracytoplasmic sperm injection (ICSI) has separately. However, ICSI is a multifaceted procedure become an indispensable procedure of every assisted involving several consecutive steps and when evaluating one reproduction unit. This has created as much controversy as we cannot exclude the end effect of the previous, or the it has awe. As this is a multistep invasive technique, every overall effect of the different practitioners involved form part of the procedure has become subject to investigation. beginning to end. We contribute this review aspiring to offer the embryologist insight into all available approaches of securing an effective Recent global demographic surveys indicate that infertility ICSI practice. Herein we present all the different approaches remains an ongoing reproductive problem and is estimated with respect to handling of the human oocyte, taking into to affect as many as 186 million people worldwide (1) . The consideration the important steps of the technique such as assisted reproductive technology (ART) community is the oocyte positioning, timing of performing ICSI, the option committed to working towards not just a positive pregnancy of viewing the meiotic spindle and further individual action test but rather striving to secure excellent obstetric and such as artificial oocyte activation, rescue ICSI and in vitro perinatal outcomes.
    [Show full text]
  • Analysis of Nine Chromosome Probes in First Polar Bodies and Metaphase II Oocytes for the Detection of Aneuploidies
    European Journal of Human Genetics (2003) 11, 325–336 & 2003 Nature Publishing Group All rights reserved 1018-4813/03 $25.00 www.nature.com/ejhg ARTICLE Analysis of nine chromosome probes in first polar bodies and metaphase II oocytes for the detection of aneuploidies Aı¨da Pujol*,1, Irene Boiso2, Jordi Benet1, Anna Veiga2, Merce` Durban1, Mercedes Campillo3, Josep Egozcue1 and Joaquima Navarro1 1Departament de Biologia Cel.lular, Fisiologia i Immunologia, Unitat de Biologia, Facultat de Medicina, Universitat Auto`noma de Barcelona, E-08193 Bellaterra, Spain; 2Servei de Medicina de la Reproduccio´, Institut Universitari Dexeus, Pg. Bonanova 89-91, E-08017 Barcelona, Spain; 3Laboratori de Medicina Computacional, Unitat de Bioestadı´stica, Facultat de Medicina, Universitat Auto`noma de Barcelona, Spain We used fluorescent in situ hybridisation (FISH) to detect nine chromosomes (1, 13, 15, 16, 17, 18, 21, 22 and X) in 89 first Polar Bodies (1PBs), from in vitro matured oocytes discarded from IVF cycles. In 54 1PBs, we also analysed the corresponding oocyte in metaphase II (MII) to confirm the results; the other 35 1PBs were analysed alone as when preimplantation genetic diagnosis using 1PB (PGD-1PB) is performed. The frequency of aneuploid oocytes found was 47.5%; if the risk of aneuploidy for 23 chromosomes is estimated, the percentage rises to 57.2%. Missing chromosomes or chromatids found in 1PBs of 1PB/MII doublets were confirmed by MII results in 74.2%, indicating that only 25.8% of them were artefactual. Abnormalities observed in 1PBs were 55.8% whole-chromosome alterations and 44.2% chromatid anomalies. We observed a balanced predivision of chromatids for all chromosomes analysed.
    [Show full text]
  • Regulation of Dynamic Events by Microfilaments During Oocyte Maturation and Fertilization
    REPRODUCTIONREVIEW Regulation of dynamic events by microfilaments during oocyte maturation and fertilization Qing-Yuan Sun1,2 and Heide Schatten2 1State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100080, China and 2Department of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA Correspondence should be addressed to H Schatten; Email: [email protected] Abstract Actin filaments (microfilaments) regulate various dynamic events during oocyte meiotic maturation and fertilization. In most species, microfilaments are not required for germinal vesicle breakdown and meiotic spindle formation, but they mediate per- ipheral nucleus (chromosome) migration, cortical spindle anchorage, homologous chromosome separation, cortex develop- ment/maintenance, polarity establishment, and first polar body emission during oocyte maturation. Peripheral cortical granule migration is controlled by microfilaments, while mitochondria movement is mediated by microtubules. During fertilization, microfilaments are involved in sperm incorporation, spindle rotation (mouse), cortical granule exocytosis, second polar body emission and cleavage ring formation, but are not required for pronuclear apposition (except for the mouse). Many of the events are driven by the dynamic interactions between myosin and actin filaments whose polymerization is regulated by RhoA, Cdc42, Arp2/3 and other signaling molecules. Studies have also shown that oocyte cortex organization and polarity formation mediated by
    [Show full text]
  • Mitochondrial DNA Replacement Techniques to Prevent Human Mitochondrial Diseases
    International Journal of Molecular Sciences Review Mitochondrial DNA Replacement Techniques to Prevent Human Mitochondrial Diseases Luis Sendra 1,2 , Alfredo García-Mares 2, María José Herrero 1,2,* and Salvador F. Aliño 1,2,3 1 Unidad de Farmacogenética, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain; [email protected] (L.S.); [email protected] (S.F.A.) 2 Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain; [email protected] 3 Unidad de Farmacología Clínica, Área del Medicamento, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-961-246-675 Abstract: Background: Mitochondrial DNA (mtDNA) diseases are a group of maternally inherited genetic disorders caused by a lack of energy production. Currently, mtDNA diseases have a poor prognosis and no known cure. The chance to have unaffected offspring with a genetic link is important for the affected families, and mitochondrial replacement techniques (MRTs) allow them to do so. MRTs consist of transferring the nuclear DNA from an oocyte with pathogenic mtDNA to an enucleated donor oocyte without pathogenic mtDNA. This paper aims to determine the efficacy, associated risks, and main ethical and legal issues related to MRTs. Methods: A bibliographic review was performed on the MEDLINE and Web of Science databases, along with searches for related clinical trials and news. Results: A total of 48 publications were included for review. Five MRT procedures were identified and their efficacy was compared. Three main risks associated with MRTs were discussed, and the ethical views and legal position of MRTs were reviewed.
    [Show full text]
  • Incorporation of the Acrosome Into the Oocyte During Intracytoplasmic Sperm Injection Could Be Potentially Hazardous to Embryo Development
    Incorporation of the acrosome into the oocyte during intracytoplasmic sperm injection could be potentially hazardous to embryo development Kazuto Morozumi and Ryuzo Yanagimachi* Institute for Biogenesis Research, University of Hawaii School of Medicine, Honolulu, HI 96822 Contributed by Ryuzo Yanagimachi, August 12, 2005 In mice and humans, a normal offspring can be obtained by the acrosome may have some effects on the development of injecting a single spermatozoon into an oocyte, the process called embryos. intracytoplasmic sperm injection (ICSI). When three or more mouse In this study, we investigated how mouse oocytes respond to spermatozoa with intact acrosomes were injected into individual injection of a single or multiple spermatozoa with or without their mouse oocytes, an increasing proportion of oocytes became de- acrosomes. The effects of the injection of hydrolyzing enzymes formed and lysed. Oocytes did not deform and lyse when acro- (trypsin and hyaluronidase) on oocytes and embryos were also some-less spermatozoa were injected, regardless of the number of examined. spermatozoa injected. Injection of more than four human sperma- tozoa into a mouse oocyte produced vacuole-like structures in each Materials and Methods oocyte. This vacuolation did not happen when spermatozoa were Reagents and Media. All inorganic and organic reagents were freed from acrosomes before injection. Hamsters, cattle, and pigs purchased from Sigma unless otherwise stated. The medium used have much larger acrosomes than the mouse or human. Injection for culturing oocytes after ICSI was bicarbonate-buffered Chatot, of a single acrosome-intact hamster, bovine, and porcine sperma- Ziomet and Bavister (CZB) medium supplemented with 5.56 mM tozoon deformed and lysed many or all mouse oocytes.
    [Show full text]